Clinical Study
TRAF1 Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis
Table 1
Main demographic and laboratory data of 179 patients with primary biliary cirrhosis.
| | Feature | PBC () |
| | Age (median; range) | 56 (22–80) | | Gender (M/F) | 21/158 | | Biopsy confirmed cirrhosis (Y/N) | 46/86 | | AMA (pos/neg) | 155/24 | | ALT (median; range), IU/L (: 3–30) | 84 (10–727) | | ALP (median; range ), IU/L (: 40–120) | 323 (37–2264) | | GGT (median; range), IU/L (: 3–30) | 302 (11–2608) | | Bilirubin (median; range), mg/dL (: 0.2–1.0) | 3.0 (0.2–40.5) | | Albumin (median; range), g/dL (: 3.8–4.4) | 3.6 (2.1–5.2) | | INR (median; range) (: 0.8–1.2) | 1.0 (0.8–2.3) | | Cholesterol (median; range ), mg/dL () | 238 (50–709) | | Triglycerides (median; range), mg/dL () | 124 (42–334) |
|
|
AMA: antimitochondrial antibody; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; INR: international normalized ratio.
|
